Table 3.

Median Overall Survival

Factor	Stage I/II Survival (mos) Median (95% CI)	Stage III Survival (mos) Median (95% CI)	Stage IV Survival (mos) Median (95% CI)
HIV
Yes	26 (15–59)	12 (7–16)	6 (4–6)
No	43 (38–47)	10 (9–11)	6 (6–7)
Hazard ratio (95% CI)	1.48 (1.06, 2.07)	0.98 (0.72, 1.32)	1.27 (0.97, 1.67)
P-value*	0.021	0.876	0.082
Receipt of guidance concordant treatment
Yes	63 (57–69)	10 (10–11)	6 (5–6)
No	21 (18–23)	9 (8–12)	7 (6–8)
Hazard ratio (95% CI)	0.35 (0.30, 0.41)	0.98 (0.85, 1.12)	1.27 (1.13, 1.44)
P-value*	<0.001	0.733	<0.001
Comorbidities
0–1	50 (43–55)	11 (10–12)	6 (6–7)
>1	29 (25–37)	9 (8–10)	5 (5–6)
Hazard ratio (95% CI)	1.39 (1.17, 1.64)	1.11 (0.96, 1.28)	1.06 (0.92, 1.22)
P-value*	<0.001	0.151	0.451
Urban/Rural
Big Metro	38 (33–43)	10 (9–11)	6 (5–6)
Other	47 (41–55)	11 (10–12)	7 (6–8)
Hazard ratio (95% CI)	0.98 (0.81, 1.18)	1.05 (0.89, 1.22)	1.01 (0.87, 1.17)
P-value*	0.796	0.578	0.871
Married
Yes	47 (41–54)	11(10–12)	6 (6–7)
No	36 (32–41)	10 (9–11)	6 (5–6)
Hazard ratio (95% CI)	0.89 (0.76, 1.04)	0.89 (0.78, 1.02)	0.92 (0.81, 1.04)
P-value*	0.155	0.085	0.199

^*Based on multivariate stratified proportional hazards model